Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Platelets | 11 | 2024 | 731 | 2.750 |
Why?
|
| P-Selectin | 4 | 2020 | 124 | 1.850 |
Why?
|
| Leukocytes | 4 | 2022 | 422 | 1.640 |
Why?
|
| Vimentin | 4 | 2024 | 253 | 1.550 |
Why?
|
| Intravital Microscopy | 2 | 2022 | 33 | 1.010 |
Why?
|
| Membrane Glycoproteins | 3 | 2020 | 1073 | 0.920 |
Why?
|
| Neutrophils | 3 | 2021 | 835 | 0.880 |
Why?
|
| Thrombosis | 6 | 2022 | 781 | 0.860 |
Why?
|
| Endotoxemia | 2 | 2020 | 61 | 0.820 |
Why?
|
| Cell Adhesion | 2 | 2020 | 1008 | 0.750 |
Why?
|
| von Willebrand Diseases | 2 | 2022 | 61 | 0.740 |
Why?
|
| Endothelium, Vascular | 2 | 2018 | 891 | 0.730 |
Why?
|
| Histones | 3 | 2022 | 1466 | 0.730 |
Why?
|
| Acetaminophen | 2 | 2021 | 116 | 0.680 |
Why?
|
| Platelet Aggregation | 2 | 2024 | 257 | 0.650 |
Why?
|
| Liver Transplantation | 6 | 2023 | 1112 | 0.620 |
Why?
|
| Pneumonia | 1 | 2024 | 751 | 0.620 |
Why?
|
| Recombinant Proteins | 3 | 2021 | 2927 | 0.580 |
Why?
|
| Corneal Injuries | 2 | 2021 | 29 | 0.570 |
Why?
|
| Epithelium, Corneal | 3 | 2021 | 223 | 0.560 |
Why?
|
| Receptors, Proteinase-Activated | 1 | 2015 | 2 | 0.550 |
Why?
|
| Antithrombin III | 1 | 2015 | 28 | 0.540 |
Why?
|
| Corneal Keratocytes | 1 | 2015 | 5 | 0.530 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2015 | 193 | 0.470 |
Why?
|
| Peptide Hydrolases | 1 | 2015 | 256 | 0.470 |
Why?
|
| End Stage Liver Disease | 3 | 2021 | 170 | 0.460 |
Why?
|
| Hepatocytes | 1 | 2015 | 351 | 0.460 |
Why?
|
| von Willebrand Factor | 5 | 2022 | 335 | 0.450 |
Why?
|
| Microcirculation | 3 | 2022 | 200 | 0.440 |
Why?
|
| Leukapheresis | 2 | 2023 | 152 | 0.440 |
Why?
|
| Serum Albumin | 1 | 2013 | 257 | 0.430 |
Why?
|
| Lung Transplantation | 3 | 2022 | 359 | 0.430 |
Why?
|
| Endothelium | 2 | 2022 | 158 | 0.390 |
Why?
|
| Wound Healing | 2 | 2021 | 815 | 0.390 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 3 | 2021 | 184 | 0.350 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2015 | 1242 | 0.340 |
Why?
|
| Cystic Fibrosis | 2 | 2022 | 264 | 0.340 |
Why?
|
| Disseminated Intravascular Coagulation | 2 | 2020 | 106 | 0.340 |
Why?
|
| Sepsis | 3 | 2022 | 652 | 0.330 |
Why?
|
| Acute-On-Chronic Liver Failure | 2 | 2021 | 59 | 0.330 |
Why?
|
| Biliary Atresia | 2 | 2023 | 191 | 0.320 |
Why?
|
| Animals | 16 | 2024 | 59536 | 0.300 |
Why?
|
| Lab-On-A-Chip Devices | 2 | 2024 | 25 | 0.280 |
Why?
|
| Multiple Organ Failure | 3 | 2022 | 177 | 0.270 |
Why?
|
| Inflammation | 5 | 2022 | 2522 | 0.260 |
Why?
|
| Cardiomyopathies | 2 | 2023 | 610 | 0.260 |
Why?
|
| Mice | 12 | 2024 | 34495 | 0.260 |
Why?
|
| Venules | 2 | 2022 | 27 | 0.260 |
Why?
|
| Endothelial Cells | 1 | 2010 | 1048 | 0.250 |
Why?
|
| Mice, Inbred C57BL | 7 | 2021 | 6942 | 0.240 |
Why?
|
| Factor XIII Deficiency | 1 | 2024 | 4 | 0.240 |
Why?
|
| Intracranial Hemorrhage, Traumatic | 1 | 2024 | 11 | 0.240 |
Why?
|
| Cell Separation | 4 | 2024 | 612 | 0.230 |
Why?
|
| Blood Component Removal | 1 | 2023 | 121 | 0.230 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 2 | 2021 | 164 | 0.230 |
Why?
|
| Critical Care | 2 | 2021 | 770 | 0.230 |
Why?
|
| Ferritins | 2 | 2021 | 151 | 0.230 |
Why?
|
| Child | 20 | 2024 | 29154 | 0.220 |
Why?
|
| Craniocerebral Trauma | 1 | 2024 | 130 | 0.220 |
Why?
|
| Hemostatics | 1 | 2022 | 88 | 0.210 |
Why?
|
| Liver | 2 | 2022 | 2961 | 0.210 |
Why?
|
| Chemical and Drug Induced Liver Injury, Chronic | 1 | 2021 | 2 | 0.200 |
Why?
|
| Chitinase-3-Like Protein 1 | 1 | 2021 | 18 | 0.200 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2021 | 18 | 0.200 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2024 | 222 | 0.200 |
Why?
|
| Liver Cirrhosis | 4 | 2023 | 941 | 0.200 |
Why?
|
| Hyperemia | 1 | 2021 | 40 | 0.200 |
Why?
|
| Cell Degranulation | 1 | 2021 | 47 | 0.200 |
Why?
|
| CD18 Antigens | 1 | 2021 | 83 | 0.200 |
Why?
|
| Vasculitis | 1 | 2021 | 61 | 0.200 |
Why?
|
| Interferometry | 1 | 2020 | 23 | 0.190 |
Why?
|
| Thromboembolism | 1 | 2022 | 155 | 0.190 |
Why?
|
| ADAMTS13 Protein | 1 | 2021 | 92 | 0.190 |
Why?
|
| Humans | 34 | 2024 | 261506 | 0.190 |
Why?
|
| Virus Replication | 1 | 2024 | 709 | 0.190 |
Why?
|
| Critical Illness | 6 | 2022 | 714 | 0.180 |
Why?
|
| Molecular Docking Simulation | 1 | 2020 | 144 | 0.180 |
Why?
|
| Erythrocytes | 1 | 2021 | 339 | 0.180 |
Why?
|
| Healthy Volunteers | 1 | 2020 | 187 | 0.180 |
Why?
|
| Respiration, Artificial | 1 | 2023 | 577 | 0.180 |
Why?
|
| Mast Cells | 1 | 2021 | 223 | 0.180 |
Why?
|
| Centrifugation | 3 | 2024 | 66 | 0.180 |
Why?
|
| Protein Domains | 1 | 2020 | 314 | 0.170 |
Why?
|
| Tracheostomy | 1 | 2021 | 243 | 0.170 |
Why?
|
| Biliary Tract Diseases | 1 | 2018 | 61 | 0.160 |
Why?
|
| Extracorporeal Circulation | 1 | 2018 | 43 | 0.160 |
Why?
|
| Typhus, Endemic Flea-Borne | 1 | 2018 | 19 | 0.160 |
Why?
|
| Coronary Care Units | 1 | 2017 | 46 | 0.150 |
Why?
|
| Escherichia coli | 1 | 2024 | 1203 | 0.150 |
Why?
|
| Fibrin | 3 | 2022 | 82 | 0.150 |
Why?
|
| Plasma Exchange | 1 | 2018 | 117 | 0.150 |
Why?
|
| Perioperative Care | 1 | 2021 | 451 | 0.150 |
Why?
|
| Transportation of Patients | 1 | 2017 | 59 | 0.150 |
Why?
|
| Bacterial Infections | 1 | 2021 | 479 | 0.150 |
Why?
|
| Renal Replacement Therapy | 1 | 2018 | 135 | 0.150 |
Why?
|
| Male | 16 | 2023 | 123000 | 0.140 |
Why?
|
| Cornea | 1 | 2021 | 638 | 0.140 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2017 | 441 | 0.140 |
Why?
|
| Patient Admission | 1 | 2017 | 220 | 0.140 |
Why?
|
| Fluorescent Dyes | 1 | 2018 | 459 | 0.140 |
Why?
|
| Infant | 9 | 2024 | 13310 | 0.130 |
Why?
|
| Child, Preschool | 10 | 2022 | 16273 | 0.130 |
Why?
|
| Bile Acids and Salts | 2 | 2023 | 246 | 0.130 |
Why?
|
| Anti-Infective Agents | 1 | 2018 | 446 | 0.120 |
Why?
|
| Toll-Like Receptors | 1 | 2015 | 174 | 0.120 |
Why?
|
| Chemokines | 1 | 2015 | 314 | 0.120 |
Why?
|
| Protein Binding | 1 | 2020 | 3438 | 0.120 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2020 | 1648 | 0.120 |
Why?
|
| Platelet Function Tests | 1 | 2013 | 50 | 0.110 |
Why?
|
| Microfluidics | 2 | 2023 | 33 | 0.110 |
Why?
|
| Liver Diseases | 1 | 2018 | 574 | 0.110 |
Why?
|
| Thrombocytopenia | 1 | 2018 | 846 | 0.110 |
Why?
|
| Anemia | 1 | 2018 | 689 | 0.110 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2012 | 105 | 0.100 |
Why?
|
| Blood Coagulation Disorders | 1 | 2012 | 120 | 0.100 |
Why?
|
| Coinfection | 1 | 2012 | 189 | 0.100 |
Why?
|
| Infant, Newborn | 5 | 2023 | 8223 | 0.100 |
Why?
|
| Antibodies, Blocking | 1 | 2010 | 91 | 0.090 |
Why?
|
| Blood Cell Count | 1 | 2010 | 225 | 0.090 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2012 | 242 | 0.090 |
Why?
|
| Systemic Inflammatory Response Syndrome | 2 | 2022 | 182 | 0.090 |
Why?
|
| Female | 13 | 2023 | 141928 | 0.090 |
Why?
|
| Bile Duct Diseases | 1 | 2010 | 45 | 0.090 |
Why?
|
| Gene Deletion | 1 | 2015 | 1442 | 0.090 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 1148 | 0.090 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 7222 | 0.090 |
Why?
|
| Cell Movement | 2 | 2021 | 2466 | 0.080 |
Why?
|
| Staphylococcus aureus | 1 | 2012 | 548 | 0.080 |
Why?
|
| Retrospective Studies | 9 | 2023 | 37905 | 0.080 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2010 | 192 | 0.080 |
Why?
|
| In Vitro Techniques | 1 | 2010 | 1618 | 0.080 |
Why?
|
| Risk Factors | 5 | 2023 | 17523 | 0.080 |
Why?
|
| Mice, Knockout | 2 | 2021 | 5710 | 0.070 |
Why?
|
| Staphylococcal Infections | 1 | 2012 | 672 | 0.070 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2022 | 203 | 0.070 |
Why?
|
| Cytokines | 1 | 2015 | 2809 | 0.070 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2012 | 581 | 0.070 |
Why?
|
| Influenza, Human | 1 | 2012 | 925 | 0.060 |
Why?
|
| Adolescent | 6 | 2023 | 31252 | 0.060 |
Why?
|
| Factor XIII | 1 | 2024 | 8 | 0.060 |
Why?
|
| Filtration | 1 | 2024 | 92 | 0.060 |
Why?
|
| Myocardium | 1 | 2010 | 1313 | 0.060 |
Why?
|
| Heart | 1 | 2010 | 1223 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2018 | 5542 | 0.060 |
Why?
|
| Organ Dysfunction Scores | 1 | 2022 | 66 | 0.060 |
Why?
|
| Extracellular Space | 1 | 2022 | 132 | 0.050 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2022 | 73 | 0.050 |
Why?
|
| Fibrinolysis | 1 | 2022 | 63 | 0.050 |
Why?
|
| Fibrinogen | 1 | 2022 | 205 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2023 | 321 | 0.050 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2021 | 157 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2021 | 600 | 0.050 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2020 | 220 | 0.050 |
Why?
|
| Phagocytosis | 1 | 2021 | 260 | 0.050 |
Why?
|
| Oxidoreductases | 1 | 2021 | 171 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 7548 | 0.040 |
Why?
|
| Incidence | 2 | 2021 | 5673 | 0.040 |
Why?
|
| Collagen | 1 | 2022 | 752 | 0.040 |
Why?
|
| Waiting Lists | 1 | 2021 | 263 | 0.040 |
Why?
|
| Cold Ischemia | 1 | 2018 | 22 | 0.040 |
Why?
|
| Models, Animal | 1 | 2021 | 664 | 0.040 |
Why?
|
| Regeneration | 1 | 2021 | 279 | 0.040 |
Why?
|
| Operative Time | 1 | 2018 | 217 | 0.040 |
Why?
|
| Drug Resistance, Multiple | 1 | 2018 | 204 | 0.040 |
Why?
|
| Platelet Activation | 1 | 2018 | 116 | 0.040 |
Why?
|
| Proteome | 1 | 2021 | 561 | 0.040 |
Why?
|
| Hospitals, Urban | 1 | 2017 | 87 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2018 | 344 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2021 | 1144 | 0.040 |
Why?
|
| Doxycycline | 1 | 2018 | 178 | 0.040 |
Why?
|
| Hospitals, University | 1 | 2017 | 209 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 4320 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2018 | 429 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2021 | 32848 | 0.040 |
Why?
|
| Adult | 3 | 2023 | 77950 | 0.030 |
Why?
|
| Operating Rooms | 1 | 2017 | 122 | 0.030 |
Why?
|
| Combined Modality Therapy | 2 | 2018 | 8865 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2018 | 422 | 0.030 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2017 | 273 | 0.030 |
Why?
|
| Cause of Death | 1 | 2018 | 752 | 0.030 |
Why?
|
| Macrophages | 1 | 2021 | 1304 | 0.030 |
Why?
|
| Antibodies | 1 | 2018 | 838 | 0.030 |
Why?
|
| Graft Rejection | 1 | 2018 | 834 | 0.030 |
Why?
|
| Time Factors | 2 | 2018 | 12926 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 2017 | 399 | 0.030 |
Why?
|
| Echocardiography | 1 | 2019 | 1182 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 1559 | 0.030 |
Why?
|
| Methylmalonic Acid | 1 | 2012 | 15 | 0.030 |
Why?
|
| Vasoplegia | 1 | 2012 | 10 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 4744 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 4314 | 0.030 |
Why?
|
| Medical Audit | 1 | 2012 | 188 | 0.030 |
Why?
|
| Dicarbethoxydihydrocollidine | 1 | 2010 | 4 | 0.020 |
Why?
|
| Length of Stay | 1 | 2017 | 1900 | 0.020 |
Why?
|
| Glycogen | 1 | 2010 | 80 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2017 | 2218 | 0.020 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2010 | 97 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2021 | 9180 | 0.020 |
Why?
|
| Phenotype | 2 | 2012 | 6295 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 4298 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2010 | 318 | 0.020 |
Why?
|
| Respiratory Insufficiency | 1 | 2012 | 330 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2010 | 401 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2018 | 6100 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 4988 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2010 | 448 | 0.020 |
Why?
|
| Disease Progression | 1 | 2018 | 6682 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 6207 | 0.020 |
Why?
|
| Fibrosis | 1 | 2010 | 793 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2010 | 488 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2019 | 9244 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 12873 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 2992 | 0.020 |
Why?
|
| Fatigue | 1 | 2010 | 1239 | 0.010 |
Why?
|
| Prognosis | 1 | 2021 | 21713 | 0.010 |
Why?
|
| Gene Expression | 1 | 2010 | 3570 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 14889 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2012 | 6869 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2010 | 11965 | 0.010 |
Why?
|